Signaling pathways predisposing to chronic kidney disease progression
Authors:
- Mohamad ZaidanMZMohamad Zaidan
- Martine BurtinMBMartine Burtin
- Jitao David ZhangJZJitao David Zhang
- Thomas BlancTBThomas Blanc
- Pauline BarrePBPauline Barre
- Serge GarbaySGSerge Garbay
- Florence VasseurFVFlorence Vasseur
- Lucie YammineLYLucie Yammine
- Serena GermanoSGSerena Germano
- Laura BadiLBLaura Badi
- Marie-Claire GublerMGMarie-Claire Gubler
Open Access
- 7 May 2020
- journal article
- research article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 5 (9)
Abstract
The loss of functional nephrons after kidney injury triggers the compensatory growth of the remaining ones to allow functional adaptation. However, in some cases, these compensatory events activate signaling pathways that lead to pathological alterations and chronic kidney disease. Little is known about the identity of these pathways and how they lead to the development of renal lesions. Here, we combined mouse strains that differently react to nephron reduction with molecular and temporal genome-wide transcriptome studies to elucidate the molecular mechanisms involved in these events. We demonstrated that nephron reduction led to 2 waves of cell proliferation: the first one occurred during the compensatory growth regardless of the genetic background, whereas the second one occurred, after a quiescent phase, exclusively in the sensitive strain and accompanied the development of renal lesions. Similarly, clustering by coinertia analysis revealed the existence of 2 waves of gene expression. Interestingly, we identified type I interferon (IFN) response as an early (first-wave) and specific signature of the sensitive (FVB/N) mice. Activation of type I IFN response was associated with G 1 /S cell cycle arrest, which correlated with p21 nuclear translocation. Remarkably, the transient induction of type I IFN response by poly(I:C) injections during the compensatory growth resulted in renal lesions in otherwise-resistant C57BL6 mice. Collectively, these results suggest that the early molecular and cellular events occurring after nephron reduction determine the risk of developing late renal lesions and point to type I IFN response as a crucial event of the deterioration process.Keywords
Funding Information
- Institut National de la Santé et de la Recherche Médicale (Institut National de la Santé et de la Recherche Médicale)
- Université Paris Descartes (Université Paris Descartes)
- Assistance Publique - Hôpitaux de Paris (Assistance Publique Hôpitaux de Paris)
- Agence Nationale Recherche (SIGNA-KID)
- Whoami Laboratoire d’Excellence (Whoami Laboratoire d’Excellence)
- Pharma Research and Early Development Roche Laboratories (Pharma Research)
- Pharma Research and Early Development Roche Laboratories (Early Development Roche Laboratories)
- Institut Roche de Recherche et Médecine Translationnelle (Institut Roche de Recherche et Médecine Translationnelle)
This publication has 44 references indexed in Scilit:
- A transcriptional network underlies susceptibility to kidney disease progressionEMBO Molecular Medicine, 2012
- TGF-α Mediates Genetic Susceptibility to Chronic Kidney DiseaseJournal of the American Society of Nephrology, 2011
- Lipocalin 2 is essential for chronic kidney disease progression in mice and humansJournal of Clinical Investigation, 2010
- Type I interferon: friend or foe?Journal of Experimental Medicine, 2010
- Type I Interferons Produced by Resident Renal Cells May Promote End-Organ Disease in Autoantibody-Mediated GlomerulonephritisThe Journal of Immunology, 2009
- Interferon-inducible antiviral effectorsNature Reviews Immunology, 2008
- TLR4 activation mediates kidney ischemia/reperfusion injuryJournal of Clinical Investigation, 2007
- Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetesJournal of Clinical Investigation, 2006
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences, 2005
- The course of the remnant kidney model in miceKidney International, 1999